LifeTech Scientific Corporation (HKG:1302)

Market Cap	6.81B -30.7%
Revenue (ttm)	1.52B +5.1%
Net Income	164.50M -33.5%
EPS	0.04 -35.0%
Shares Out	4.63B
PE Ratio	40.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	15,500,000
Open	1.430
Previous Close	1.400
Day's Range	1.380 - 1.470
52-Week Range	1.300 - 2.440
Beta	0.32
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About LifeTech Scientific

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. It is also involved in biomedical research and development; properties leasing business; and developing,...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 1,245
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1302

Financial Performance

In 2025, LifeTech Scientific's revenue was 1.37 billion, an increase of 5.07% compared to the previous year's 1.30 billion. Earnings were 147.83 million, a decrease of -33.53%.

Financial numbers in CNY

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 31, 2026

Data Sources Report a data error